It was reported a decrease on RECORDATI INDUSTRIA CHIMICA E FARMACEUTI (OTCMKTS:RCDTF)’s short interest with 2.04%. FINRA issued short interest of RCDTF’s total 350,500 shares. The 357,800 previous shares are down with 2.04%.

At traded at $34.7 lastly.Since February 16, 2018 it’s 0.00% down thus . The stock the S&P500 by 0.00%.

Recordati S.p.A. engages in the research, development, manufacture, marketing, and sale of pharmaceuticals.The company has $7.99 billion market cap. The firm offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, musculo-skeletal disorders and analgesia, pregnancy test, urology, OTC/non-prescription pharmaceuticals, allergy, antiinfectives, central nervous system, endocrinology, gastrointestinal, gynecology, obstetrics, nutrition and related areas, immunosuppressants, pediatrics, pneumology, hematology, oncology, respiratory, and generics.Currently it has negative earnings. Further, the firm produces pharmaceutical chemicals, such as active pharmaceutical ingredients and intermediates.

More recent Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) news were released by, and The first one has “Recordati (RCDTF) Presents At Jefferies 2018 Global Healthcare Conference – Slideshow – Seeking Alpha” as a title and was released on June 07, 2018. The next is “Recordati Industria Chimica e Farmaceutica S.p.A. 2018 Q2 – Results – Earnings Call Slides – Seeking Alpha” on July 26, 2018. And last was released on May 24, 2018, called “Recordati: A Somehow Boring But Interesting Pharmaceutical Company – Seeking Alpha”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.